How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-covid-19-in-individuals-6-months-of-age-and-older.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of COVID-19 in individuals 6 months of age and older — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of COVID-19 in individuals 6 months of age and older (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of COVID-19 in individuals 6 months of age and older, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	vaccine	SARS-CoV-2 virus	2021-08-23
Covid-19 Sterilizing	COVID-19 Vaccine	Pfizer	vaccine	SARS-CoV-2
Tozinameran 6 months to 4 years of age	tozinameran-6-months-to-4-years-of-age	Pfizer	vaccine	SARS-CoV-2 spike protein
Pfizer-BioNTech COVID-19 mRNA vaccine	Pfizer-BioNTech COVID-19 mRNA vaccine	Pfizer	vaccine	SARS-CoV-2
BNT162b2 (Omi XBB.1.5)/RIV	bnt162b2-omi-xbb-1-5-riv	Pfizer	vaccine	SARS-CoV-2
Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose	variant-adapted-bnt162b2-omicron-xbb-1-5-3-microgram-dose	Pfizer	mRNA vaccine	SARS-CoV-2
BNT162b2 (Omi XBB.1.5)	bnt162b2-omi-xbb-1-5	Pfizer	mRNA vaccine	SARS-CoV-2 spike protein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 6 drugs in Prevention of COVID-19 in individuals 6 months of age and older
Pfizer Inc. · 1 drug in Prevention of COVID-19 in individuals 6 months of age and older

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of COVID-19 in individuals 6 months of age and older:

Cite this brief

Drug Landscape (2026). Prevention of COVID-19 in individuals 6 months of age and older — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-covid-19-in-individuals-6-months-of-age-and-older. Accessed 2026-06-10.

Prevention of COVID-19 in individuals 6 months of age and older full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing